DTP Communications March, 2017 Formulary Addition and Criteria Emtricitabine-tenofovir alafenamide (Descovyâ„¢) February, 2017 Notice of Change Generic Antiretroviral Products August, 2015 Formulary Addition Dolutegravir-abacavir-lamivudine (Triumeqâ„¢) and Darunavir-cobicistat (Prezcobixâ„¢) June, 2014 Notice of Change to Forms Drug Treatment Program Enrolment and Prescription Request Forms April, 2014 Formulary Addition Dolutegravir (Tivicayâ„¢) May, 2013 Notice to prescribers and clients Drug Treatment Program Registry – Program Information Sheet Click here to link to the Drug Treatment Program Participant Information Sheet May, 2013 Formulary Addition Elvitegravir-cobicistat-emtricitabine-tenofovir DF (Stribildâ„¢) August, 2012 Formulary Addition Rilpivirine-emtricitabine-tenofovir DF (Compleraâ„¢) & Rilpivirine (Edurantâ„¢) April, 2012 Formulary Addition Nevirapine Immediate Release (Viramuneâ„¢ IR) and Nevirapine Extended Release (Viramuneâ„¢ XR) Tablets Page1 Page2 Page3